Partner Fund Management »

Oruka Therapeutics shares owned by Partner Fund Management

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.5M 174k 49.05

More positions owned by Partner Fund Management

Tenet Healthcare Corp Com New (THC)
United Therapeutics Corporation (UTHR)
Eli Lilly & Co. (LLY)
Spdr Series Trust State Street Spd Put Option (XBI)
Penumbra (PEN)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads
Inhibrx Biosciences (INBX)
Edwards Lifesciences (EW)
Bridgebio Pharma (BBIO)

View all positions for Partner Fund Management

Top funds holding Oruka Therapeutics

FMR
VR Adviser
Fairmount Funds Management
BlackRock
Viking Global Investors
Paradigm Biocapital Advisors
Rtw Investments
Deep Track Capital
Vanguard Capital Management
State Street Corporation
Remedium Capital Partners
Perceptive Advisors
Polar Capital Holdings
Citadel Advisors
Franklin Resources

View all funds holding Oruka Therapeutics